Dr. William Bulman is the Medical Director of Pulmonology at Veracyte, focusing on genomic diagnostics for lung cancer and interstitial lung disease. An MD from the University of Pennsylvania with 25 years of clinical experience, he leads multi-center trials and remains an Associate Professor of Clinical Medicine at Columbia University.
He previously served as the Director of Bronchoscopy and Director of the Lung Nodule Assessment Center while at Columbia University.
William Bulman
Medical Director, Pulmonology (Lung Cancer and Interstitial Lung Disease) at Veracyte, Inc.
Pelham, New York, United States
Overview
Topics They Care About
Genomic Diagnostics
Leads medical and clinical affairs at Veracyte, focusing on genomic classifiers for pulmonary diseases, and has co-authored multiple studies on the topic.
Pulmonary Disease
A board-certified pulmonologist specializing in interstitial lung disease (ILD) and lung cancer. He previously directed Columbia's Lung Nodule Assessment Center.
Clinical Trial Leadership
His primary role at Veracyte involves leading clinical affairs, which includes managing multiple multi-center trials in both the United States and Europe.
Media Appearances
William has no verified media appearances
Work History
2-2021
Medical Director, Pulmonology (Lung Cancer and Interstitial Lung Disease) at Veracyte, Inc.
6-1994 - 2-2021
Associate Professor of Clinical Medicine at Columbia University Irving Medical Center
Education
9-1989 - 6-1994
Doctor of Medicine - MD from University of Pennsylvania
More Information
Social Presence :
Prographics :
Exp : 31
Location : Pelham, New York, United States
Job Level : Mid-senior
Designation : Medical Director, Pulmonology (Lung Cancer and Interstitial Lung Disease) at Veracyte, Inc.
